ADMA Biologics, Inc. (ADMA)
8.04
+0.07
(+0.88%)
USD |
NASDAQ |
Jun 08, 13:34
ADMA Biologics Market Cap : 1.868B for June 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Catalyst Pharmaceuticals, Inc. | 3.822B |
| Inovio Pharmaceuticals, Inc. | 76.05M |
| Zenas BioPharma, Inc. | 1.081B |
| Marker Therapeutics, Inc. | 23.68M |
| Praxis Precision Medicines, Inc. | 7.120B |
Market Cap Related Metrics
| PE Ratio | 11.86 |
| PS Ratio | 3.852 |
| Price to Book Value | 4.785 |
| Price to Free Cash Flow | 18.26 |
| Price | 8.04 |
| Earnings Yield | 8.43% |
| Operating PE Ratio | 9.494 |
| Normalized PE Ratio | 11.70 |